Page last updated: 2024-08-23

simvastatin and Hibernation, Myocardial

simvastatin has been researched along with Hibernation, Myocardial in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonow, RO; Gheorghiade, M; Kim, RJ; Klein, L; Stone, NJ1
Ichihara, K1
Abiko, Y; Ichihara, K; Satoh, K1
Hoshi, K; Ichihara, K; Satoh, K; Yamamoto, A1
Ichihara, K; Satoh, K1

Reviews

1 review(s) available for simvastatin and Hibernation, Myocardial

ArticleYear
[Myocardial dysfunction].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2006, Volume: 127, Issue:6

    Topics: Animals; Cardiomyopathies; Clinical Trials as Topic; Coenzymes; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Stunning; Myocardium; Oils; Pravastatin; Simvastatin; Solubility; Ubiquinone; Water

2006

Other Studies

4 other study(ies) available for simvastatin and Hibernation, Myocardial

ArticleYear
Improvement in the function of hibernating myocardium in a patient with heart failure due to coronary artery disease receiving high-dose simvastatin.
    Italian heart journal : official journal of the Italian Federation of Cardiology, 2004, Volume: 5, Issue:2

    Topics: Aged; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Myocardial Contraction; Myocardial Stunning; Simvastatin; Stroke Volume; Ventricular Dysfunction, Left

2004
Influences of pravastatin and simvastatin, HMG-CoA reductase inhibitors, on myocardial stunning in dogs.
    Journal of cardiovascular pharmacology, 1993, Volume: 22, Issue:6

    Topics: Adenosine Triphosphate; Administration, Oral; Animals; Blood Pressure; Carbohydrate Metabolism; Cholesterol; Dogs; Energy Metabolism; Female; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Myocardial Stunning; Myocardium; Pravastatin; Simvastatin; Ventricular Function, Left

1993
[Are all HMG-CoA reductase inhibitors protective against ischemic heart disease?].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1999, Volume: 114 Suppl 1

    Topics: Adenosine Triphosphate; Animals; Atorvastatin; Dogs; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Myocardial Contraction; Myocardial Ischemia; Myocardial Stunning; Myocardium; Pravastatin; Pyridines; Pyrroles; Simvastatin

1999
Lipophilic HMG-CoA reductase inhibitors increase myocardial stunning in dogs.
    Journal of cardiovascular pharmacology, 2000, Volume: 35, Issue:2

    Topics: Adenosine Triphosphate; Animals; Atorvastatin; Cholesterol; Dogs; Fatty Acids, Monounsaturated; Female; Fluvastatin; Hemodynamics; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Myocardial Reperfusion Injury; Myocardial Stunning; Perfusion; Pyridines; Pyrroles; Random Allocation; Simvastatin; Solubility; Time Factors

2000